Stock Taper
SCREENER COMPARE ANY 2 STOCKS
COYA
COYA THERAPEUTICS, INC.
NASDAQ
$4.87
▲ UP 0.21% (0.01)

KEY STATISTICS

Market Cap$114.24 M
52w High$7.75
52w Low$3.71
Dividend Yield—
Frequency—
P/E-4.68
Volume70.95K
Shares Out.23.46M

COMPANY

LEADERSHIP

Arun Swaminathan
CHIEF EXECUTIVE
Arun Swaminathan

COMPENSATION 2026

Salary$546,000
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$0
Total$2,091,007

ABOUT

SECTOR
Healthcare
WENT PUBLIC
December 29, 2022
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
8

PRICE TARGET

Target High$12.00
Target Low$12.00
Target Median$12.00
Target Consensus$12.00

UPCOMING EARNINGS

DateNov 11, 2026
DayWednesday
Rev. Est.$110.00K
NOV
11
WED

PRICE

$4.87 ▲ UP 0.21% (+$0.01)
$4.80$4.85$4.90$4.959:34 AM10:38 AM11:42 AM12:46 PM1:51 PM2:55 PM3:59 PM4.87

About Coya Therapeutics, Inc.

https://www.coyatherapeutics.com ↗

Coya Therapeutics, a clinical-stage biotech founded in 2020, develops Treg-based therapies—including biologics, exosomes, and cell therapies—for neurodegenerative, autoimmune, and metabolic diseases.

INDUSTRY

Biotechnology

A PRODUCT COYA THERAPEUTICS, INC. IS KNOWN FOR

COYA 302
COYA 302

Coya Therapeutics' lead investigational biologic combines therapies to boost regulatory T cell anti-inflammatory functions, aiming to treat neurodegenerative diseases like ALS, Frontotemporal Dementia, and Parkinson's Disease.

COMPETITORS

COMPETITOR
ACIU COMPARE
ALEC COMPARE
AMLX COMPARE
BIIB COMPARE
DNLI COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
19
LISTED HERE
4
RANKED BY POSITION SIZE
VTI
0.00% · 601.1K
DFAS
0.00% · 75.6K
IWC
0.02% · 66.8K
AVSC
0.00% · 11.2K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
38.01%
HOLDERS
77
TOP 12 OF 77 · RANKED BY POSITION SIZE
Dme Capital Management, LP
2.3M sh · $9.2M
Greenlight Capital Inc
1.3M sh · $9.44M
Aigh Capital Management LLC
1.1M sh · $6.3M
Vanguard Group Inc
899.1K sh · $5.22M
Alyeska Investment Group, L.P.
800.0K sh · $3.15M
Awm Investment Company, Inc.
725.0K sh · $4.21M
Prosight Management, LP
420.4K sh · $1.66M
Cm Management, LLC
375.0K sh · $1.48M
Private Management Group Inc
369.1K sh · $1.45M
Geode Capital Management, LLC
233.4K sh · $919.78K
Marshall Wace, Llp
225.8K sh · $889.62K
Dauntless Investment Group, LLC
153.0K sh · $872.22K

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book5
Overall Score2

INSIDER TRADES

★
DIRECTOR
Pavao Mark H
Purchase · 10.0K shares
2026-04-09
★
Pavao Mark H
— · —
2026-04-01
★
OFFICER: CHIEF FINANCIAL OFFICER
SNYDER DAVID S
Purchase · 140.0K shares
2026-01-22
★
OFFICER: CHIEF MEDICAL OFFICER
Grossman Fred
Purchase · 140.0K shares
2026-01-22

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 4
4 GRADES IN THE LAST 12 MONTHS
Chardan Capital BUY D. Boral Capital BUY HC Wainwright & Co. BUY BTIG BUY

SECTORS PEERS

PEERPRICE
IMMX$13.66COMPARE
STTK$7.53COMPARE
OVID$2.80COMPARE
ZNTL$3.83COMPARE
WHWK$4.73COMPARE
MGNX$4.10COMPARE
ORMP$4.81COMPARE
PLRX$1.16COMPARE